These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26894377)

  • 1. The prognostic significance of hematological parameters in women with uterine serous papillary carcinoma (USPC).
    Younes G; Segev Y; Begal J; Auslender R; Goldberg Y; Amit A; Lavie O
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():16-20. PubMed ID: 26894377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Liu XY
    Asian Pac J Cancer Prev; 2015; 16(3):933-9. PubMed ID: 25735385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
    Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
    Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas.
    Lerner DL; Walsh CS; Cass I; Karlan BY; Li AJ
    Gynecol Oncol; 2007 Jan; 104(1):91-4. PubMed ID: 16934317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Antigen 125 Levels are Significantly Associated With Prognostic Parameters in Uterine Papillary Serous Carcinoma.
    Schmidt M; Segev Y; Sadeh R; Suzan E; Feferkorn I; Kaldawy A; Kligun G; Lavie O
    Int J Gynecol Cancer; 2018 Sep; 28(7):1311-1317. PubMed ID: 29958235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
    Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
    BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary serous cancer.
    Frimer M; Hou JY; McAndrew TC; Goldberg GL; Shahabi S
    Reprod Sci; 2013 Apr; 20(4):449-55. PubMed ID: 22995987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
    Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
    Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
    Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
    Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of HER-2/neu in uterine serous papillary cancer.
    Santin AD; Bellone S; Gokden M; Palmieri M; Dunn D; Agha J; Roman JJ; Hutchins L; Pecorelli S; O'Brien T; Cannon MJ; Parham GP
    Clin Cancer Res; 2002 May; 8(5):1271-9. PubMed ID: 12006548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Gokden M; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Br J Cancer; 2004 May; 90(9):1814-24. PubMed ID: 15208622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).
    Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S
    Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer.
    Cocco E; Bellone S; El-Sahwi K; Cargnelutti M; Casagrande F; Buza N; Tavassoli FA; Siegel ER; Visintin I; Ratner E; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Br J Cancer; 2009 Jul; 101(2):335-41. PubMed ID: 19536090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.
    Hornreich G; Beller U; Lavie O; Renbaum P; Cohen Y; Levy-Lahad E
    Gynecol Oncol; 1999 Nov; 75(2):300-4. PubMed ID: 10525392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologic findings of cervicovaginal smears in women with uterine papillary serous carcinoma.
    Park JY; Kim HS; Hong SR; Chun YK
    J Korean Med Sci; 2005 Feb; 20(1):93-7. PubMed ID: 15716611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy.
    Santin AD; Zhan F; Cane' S; Bellone S; Palmieri M; Thomas M; Burnett A; Roman JJ; Cannon MJ; Shaughnessy J; Pecorelli S
    Br J Cancer; 2005 Apr; 92(8):1561-73. PubMed ID: 15785748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
    BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
    Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
    Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pretreatment hematologic profile on survival of colorectal cancer patients.
    Qiu MZ; Yuan ZY; Luo HY; Ruan DY; Wang ZQ; Wang FH; Li YH; Xu RH
    Tumour Biol; 2010 Aug; 31(4):255-60. PubMed ID: 20336401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.